318 related articles for article (PubMed ID: 17761105)
1. LAIS - Posological schedules.
Bruno M
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
[No Abstract] [Full Text] [Related]
2. LAIS Allergoid.
Mistrello G
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):21-4. PubMed ID: 17761102
[No Abstract] [Full Text] [Related]
3. Efficacy and its persistence, in children and adults.
Di Rienzo V
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
[No Abstract] [Full Text] [Related]
4. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G
Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951
[No Abstract] [Full Text] [Related]
5. Oral reactions to sublingual immunotherapy: a bioptic study.
Marcucci F; Sensi L; Incorvaia C; Di Cara G; Moingeon P; Frati F
Allergy; 2007 Dec; 62(12):1475-7. PubMed ID: 17983387
[No Abstract] [Full Text] [Related]
6. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra A; Cilia M; Pecora S; Passalacqua G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):313-4. PubMed ID: 17191752
[No Abstract] [Full Text] [Related]
7. Sublingual administration of allergen desensitization.
Reiber ME
Tenn Med; 2002 Nov; 95(11):465-7. PubMed ID: 12436862
[No Abstract] [Full Text] [Related]
8. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
Cox LS
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
[No Abstract] [Full Text] [Related]
9. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
Fiebig H; Kahlert H
Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
[No Abstract] [Full Text] [Related]
10. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
[No Abstract] [Full Text] [Related]
11. How does sublingual immunotherapy work?
Frew AJ
J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
[No Abstract] [Full Text] [Related]
12. Anaphylaxis caused by allergen sublingual immunotherapy?
André C; Fadel R
Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
[No Abstract] [Full Text] [Related]
13. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
[No Abstract] [Full Text] [Related]
14. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
[No Abstract] [Full Text] [Related]
15. [Hyposensitization in allergic diseases?].
Fuchs E
Dtsch Med Wochenschr; 1988 Jun; 113(25):1025-8. PubMed ID: 3289877
[No Abstract] [Full Text] [Related]
16. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
[No Abstract] [Full Text] [Related]
17. [Vaccination against allergies yields good symptom relief].
Hedlin G; Arvidsson M
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1938-41. PubMed ID: 18681376
[No Abstract] [Full Text] [Related]
18. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
[No Abstract] [Full Text] [Related]
19. Timothy pollen oral lyophilisate (standardised allergenic extract): new drug. Hay fever: 4 months' treatment for 4 days' relief?
Prescrire Int; 2008 Oct; 17(97):196. PubMed ID: 19536935
[No Abstract] [Full Text] [Related]
20. Adverse effects associated with sublingual immunotherapy.
Passalacqua G; Valovirta E
Clin Allergy Immunol; 2008; 21():469-75. PubMed ID: 18828524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
